Cite
HARVARD Citation
Lowenfeld, L. et al. (2017). Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer. Oncoimmunology. p. . [Online].